MG
KRMD icon

Michael Gelband’s KORU Medical Systems KRMD Stock Holding History

Michael Gelband’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,107
Closed -$127K – 2364
2020
Q4 		$127K Buy
21,107
+2,607
+14% +$14.6K ﹤0.01% 1805
2020
Q3 		$134K Sell
18,500
-5,700
-24% -$50.6K ﹤0.01% 1558
2020
Q2 		$217K Buy
24,200
+8,888
+58% +$89.8K 0.01% 1478
2020
Q1 		$115K Sell
15,312
-38,367
-71% -$258K 0.01% 870
2019
Q4 		$351K Buy
+53,679
New +$262K 0.01% 1055

Other funds holding KRMD

HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $279M AUM 54.84% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Michael Gelband's KRMD Position: Q1 2021 in Review

Michael Gelband sold out of KORU Medical Systems (KRMD) in Q1 2021, closing a stake of 21,107 shares — an estimated $127K sold.

Michael Gelband first reported a position in KRMD in Q4 2019 and held it in 5 quarters. The position peaked at $351K in Q4 2019. 72 funds tracked by Wall St. Rank hold KRMD as of Q1 2021.

  • Michael Gelband reported no remaining KORU Medical Systems position as of Q1 2021 after selling out during the quarter.
  • Michael Gelband sold 21,107 KORU Medical Systems shares in Q1 2021, an estimated $127K.
  • Michael Gelband first reported a position in KORU Medical Systems in Q4 2019 and held it in 5 quarters.
  • Michael Gelband's KORU Medical Systems position peaked at $351K in Q4 2019.
  • 72 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2021.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.